Latest News
Add-Aspirin cancer trial completes recruitment after a decade of work
Add-Aspirin has successfully completed recruitment and randomised 8,756 people who’d recently had, or are having, cancer treatment.
New second-line antiretroviral combinations are best for children living with HIV, according to CHAPAS-4 trial
These findings will help inform international guidelines and support the development of new drug combinations for children worldwide.
VIETNARMS trial offers new treatment options for people with hepatitis C
The alternative strategies aim to make it easier for patients to access and adhere to curative treatment.
The key guide to estimating hazard ratios from published data gets a major update
Comprehensively updated guidance and associated calculations spreadsheet are valuable new tools for all those conducting meta-analyses based on published time-to-event data.
New guidance on addressing barriers to sharing trial results with participants
The new guidance summarises the discussion from a workshop for trial funders, and signposts relevant resources and guidance.